相关实验视频
Updated: Jun 9, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
孕期糖尿病 - 我们可以更好地进行产后糖尿病查吗?
Hadas Zafrir-Danieli1, Ohad Houri1, Reut Rotem2
1Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, Israel.
European journal of obstetrics, gynecology, and reproductive biology
|October 31, 2024
概括
产后禁食血葡萄糖 (FPG) 测试可以准确预测妊娠糖尿病 (GDM) 的女性的2型糖尿病. 在低风险的GDM病例中,正常的FPG产后合理排除了未来的葡萄糖不耐受性.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 糖尿病研究 糖尿病研究
背景情况:
- 孕期糖尿病 (GDM) 影响母亲的健康.
- 产后血糖查对于识别患有2型糖尿病风险的妇女至关重要.
- 口服葡萄糖耐受性测试 (OGTT) 是标准的,但有合规问题.
研究的目的:
- 为了评估产后空腹血葡萄糖 (FPG) 测量在预测异常的6-12周产后口服葡萄糖耐受性测试 (OGTT) 结果在患有GDM的妇女的准确性.
- 评估FPG作为一种用于分娩后血糖异常的实际查工具.
主要方法:
- 一项回顾性队列研究分析了2012年至2021年间3128名患有GDM的女性的数据.
- 测量产后24-48小时的禁食血葡萄糖 (FPG) 水平与产后6-12周的OGTT结果进行了比较.
- 计算了预测准确度,包括负预测值 (NPV).
主要成果:
- 在接受产后OGTT的1163名妇女中,935名 (80.2%) 的FPG正常 (<100 mg/dL).
- 在低风险的GDM病例中,正常的产后FPG显示了2型糖尿病的高NPV (99.3%) 和未来葡萄糖不耐受的中度NPV (85.8%).
- 对产后OGTT的遵守率很低.
结论:
- 产后立即进行FPG检测是有效的排除低风险GDM妇女未来的2型糖尿病.
- 产后FPG是低风险GDM人群糖尿病查的实用和可靠的预测工具,特别是考虑到OGTT遵守率较低.
- 这种方法可以帮助早期识别和管理产后葡萄糖异常.
相关概念视频
Pathophysiology of Diabetes
872
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
872
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications
508
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
508
Dipeptidyl Peptidase 4 Inhibitors
172
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
172
Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K

